KERYX BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 492515951. A total of 2 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $80,000 | +42.9% | 158 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $56,000 | -70.2% | 158 | -16.0% | 0.00% | -71.4% |
| Q2 2015 | $188,000 | -35.8% | 188 | -18.3% | 0.01% | -41.7% |
| Q1 2015 | $293,000 | +61.9% | 230 | +79.7% | 0.01% | +100.0% |
| Q4 2014 | $181,000 | +31.2% | 128 | +28.0% | 0.01% | +20.0% |
| Q3 2014 | $138,000 | -98.5% | 100 | -98.1% | 0.01% | -99.0% |
| Q1 2014 | $8,926,000 | +1063.8% | 5,238 | +784.8% | 0.50% | +920.4% |
| Q4 2013 | $767,000 | -66.7% | 592 | -74.0% | 0.05% | -67.3% |
| Q3 2013 | $2,304,000 | -66.5% | 2,281 | -75.2% | 0.15% | -67.3% |
| Q2 2013 | $6,880,000 | – | 9,210 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|